Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...
New research identifies distinct urinary metabolites linked to bladder cancer and recurrence, raising hope for non-invasive ...
The Hearty Soul on MSN
Bladder cancer often starts quietly: 5 early symptoms to watch for
Bladder cancer does not always announce itself with dramatic pain or a sudden health crisis. In many people, the earliest bladder cancer symptoms look ordinary, brief, or easy to dismiss. A little ...
A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.
Bladder cancer signs and symptoms can vary from person to person. The most common symptom is blood in the urine, also called hematuria. While this can turn the urine into a red or rusty color, it may ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. BERLIN — For years, scientists have held out hope that tests that look ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results